A positively selected mutation in the WNV 2K peptide confers resistance to superinfection exclusion in vivo

Virology

Volumn 464-465, Issue 1, 2014, Pages 228-232

  Campbell, Corey L ^a   Smith, Darci R ^b   Sanchez Vargas, Irma ^a   Zhang, Bo ^c   Shi, Pei Yong ^d   Ebel, Gregory D ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c WUHAN INSTITUTE OF VIROLOGY   (China)

^d Novartis Institute for Tropical Diseases   (Singapore)

Author keywords

Flavivirus; Superinfection exclusion; Vector mosquito

Indexed keywords

METHIONINE; NONSTRUCTURAL PROTEIN 4A; PEPTIDE; PEPTIDE 2K V9M; UNCLASSIFIED DRUG; VALINE; VIRUS PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CULEX QUINQUEFASCIATUS; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFECTION RATE; MOLECULAR EVOLUTION; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUPERINFECTION; TISSUE CULTURE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; ANIMAL; CHEMISTRY; CULEX; DISEASE CARRIER; GENETICS; HUMAN; METABOLISM; MISSENSE MUTATION; PHYSIOLOGY; VIROLOGY; WEST NILE FEVER;

ANIMALS; CULEX; HUMANS; INSECT VECTORS; MUTATION, MISSENSE; SUPERINFECTION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84905378718     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.07.009     Document Type: Article

References (30)

1. Armstrong P.M., Vossbrinck C.R., Andreadis T.G., Anderson J.F., Pesko K.N., Newman R.M., Lennon N.J., Birren B.W., Ebel G.D., Henn M.R. Molecular evolution of West Nile virus in a northern temperate region: Connecticut, USA 1999-2008. Virology 2011, 417:203-210.
2. Brault A.C., Huang C.Y., Langevin S.A., Kinney R.M., Bowen R.A., Ramey W.N., Panella N.A., Holmes E.C., Powers A.M., Miller B.R. A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat. Genet. 2007, 39:1162-1166.
3. Calzolari M., Ze-Ze L., Ruzek D., Vazquez A., Jeffries C., Defilippo F., Osorio H.C., Kilian P., Ruiz S., Fooks A.R., Maioli G., Amaro F., Tlusty M., Figuerola J., Medlock J.M., Bonilauri P., Alves M.J., Sebesta O., Tenorio A., Vaux A.G., Bellini R., Gelbic I., Sanchez-Seco M.P., Johnson N., Dottori M. Detection of mosquito-only flaviviruses in Europe. J. Gen. Virol. 2012, 93:1215-1225.
4. Condreay L.D., Brown D.T. Exclusion of superinfecting homologous virus by Sindbis virus-infected Aedes albopictus (mosquito) cells. J. Virol. 1986, 58:81-86.
5. Davis C.T., Ebel G.D., Lanciotti R.S., Brault A.C., Guzman H., Siirin M., Lambert A., Parsons R.E., Beasley D.W., Novak R.J., Elizondo-Quiroga D., Green E.N., Young D.S., Stark L.M., Drebot M.A., Artsob H., Tesh R.B., Kramer L.D., Barrett A.D. Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology 2005, 342:252-265.
6. Ebel G.D., Carricaburu J., Young D., Bernard K.A., Kramer L.D. Genetic and phenotypic variation of West Nile virus in New York, 2000-2003. Am. J. Trop. Med. Hyg. 2004, 71:493-500.
7. Fitzpatrick K.A., Deardorff E.R., Pesko K., Brackney D.E., Zhang B., Bedrick E., Shi P.Y., Ebel G.D. Population variation of West Nile virus confers a host-specific fitness benefit in mosquitoes. Virology 2010, 404:89-95.
8. Hall G.S., Little D.P. Relative quantitation of virus population size in mixed genotype infections using sequencing chromatograms. J. Virol. Methods 2007, 146:22-28.
9. Herring B.L., Bernardin F., Caglioti S., Stramer S., Tobler L., Andrews W., Cheng L., Rampersad S., Cameron C., Saldanha J., Busch M.P., Delwart E. Phylogenetic analysis of WNV in North American blood donors during the 2003-2004 epidemic seasons. Virology 2007, 363:220-228.
10. Hirokawa T., Boon-Chieng S., Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998, 14:378-379.
11. Jerzak G., Bernard K.A., Kramer L.D., Ebel G.D. Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J. Gen. Virol. 2005, 86:2175-2183.
12. Karpf A.R., Lenches E., Strauss E.G., Strauss J.H., Brown D.T. Superinfection exclusion of alphaviruses in three mosquito cell lines persistently infected with Sindbis virus. J. Virol. 1997, 71:7119-7123.
13. Kilpatrick A.M., Daszak P., Jones M.J., Marra P.P., Kramer L.D. Host heterogeneity dominates West Nile virus transmission. Proc. Biol. Sci. 2006, 273:2327-2333.
14. Komar N., Langevin S., Hinten S., Nemeth N., Edwards E., Hettler D., Davis B., Bowen R., Bunning M. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg. Infect. Dis. 2003, 9:311-322.
15. Lindsey H.S., Calisher C.H., Mathews J.H. Serum dilution neutralization test for California group virus identification and serology. J. Clin. Microbiol. 1976, 4:503-510.
16. Mertens E., Kajaste-Rudnitski A., Torres S., Funk A., Frenkiel M.P., Iteman I., Khromykh A.A., Despres P. Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b. Virology 2010, 399:176-185.
17. Mitaku S., Hirokawa T., Tsuji T. Amphiphilicity index of polar amino acids as an aid in the characterization of amino acid preference at membrane-water interfaces. Bioinformatics 2002, 18:608-616.
18. Nall T.A., Chappell K.J., Stoermer M.J., Fang N.X., Tyndall J.D., Young P.R., Fairlie D.P. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease. J. Biol. Chem. 2004, 279:48535-48542.
19. Nash, D., Mostashari, F., Fine, A., Miller, J., O'Leary, D., Murray, K., Huang, A., Rosenberg, A., Greenberg, A., Sherman, M., Wong, S., Layton, M., West Nile Outbreak Response Working Group, 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344, 1807-1814.
20. Pesko K., Mores C.N. Effect of sequential exposure on infection and dissemination rates for West Nile and St. Louis encephalitis viruses in Culex quinquefasciatus. Vector Borne Zoonotic Dis. 2009, 9:281-286.
21. Pesko K.N., Fitzpatrick K.A., Ryan E.M., Shi P.Y., Zhang B., Lennon N.J., Newman R.M., Henn M.R., Ebel G.D. Internally deleted WNV genomes isolated from exotic birds in New Mexico: function in cells, mosquitoes, and mice. Virology 2012, 427:10-17.
22. Petersen L.R., Brault A.C., Nasci R.S. West Nile virus: review of the literature. JAMA 2013, 310:308-315.
23. Shi P.Y., Tilgner M., Lo M.K., Kent K.A., Bernard K.A. Infectious cDNA clone of the epidemic west nile virus from New York city. J. Virol. 2002, 76:5847-5856.
24. Shiryaev S.A., Kozlov I.A., Ratnikov B.I., Smith J.W., Lebl M., Strongin A.Y. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of dengue and West Nile viruses. Biochem. J. 2007, 401:743-752.
25. Silverman R.H. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J. Virol. 2007, 81:12720-12729.
26. Spitzer M., Wildenhain J., Rappsilber J., Tyers M. BoxPlotR: a web tool for generation of box plots. Nat. Methods 2014, 11:121-122.
27. Tyler S., Bolling B.G., Blair C.D., Brault A.C., Pabbaraju K., Armijos M.V., Clark D.C., Calisher C.H., Drebot M.A. Distribution and phylogenetic comparisons of a novel mosquito flavivirus sequence present in Culex tarsalis mosquitoes from western Canada with viruses isolated in California and Colorado. Am. J. Trop. Med. Hyg. 2011, 85:162-168.
28. Youn S., Li T., McCune B.T., Edeling M.A., Fremont D.H., Cristea I.M., Diamond M.S. Evidence for a genetic and physical interaction between nonstructural proteins NS1 and NS4B that modulates replication of West Nile virus. J. Virol. 2012, 86:7360-7371.
29. Zou G., Puig-Basagoiti F., Zhang B., Qing M., Chen L., Pankiewicz K.W., Felczak K., Yuan Z., Shi P.Y. A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor. Virology 2009, 384:242-252.
30. Zou G., Zhang B., Lim P.Y., Yuan Z., Bernard K.A., Shi P.Y. Exclusion of West Nile virus superinfection through RNA replication. J. Virol. 2009, 83:11765-11776.